Axogen Analyst Ratings
Axogen Analyst Ratings
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $9.00. The current price Axogen (AXGN) is trading at is $4.01, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/16/2023 | 124.44% | Leerink Partners | → $9 | Initiates Coverage On | → Outperform |
| 09/26/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 299% | Cantor Fitzgerald | → $16 | Reiterates | Overweight → Overweight |
| 05/10/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 03/28/2023 | 274.06% | Canaccord Genuity | → $15 | Reiterates | → Buy |
| 03/15/2023 | 398.75% | JMP Securities | → $20 | Reiterates | → Market Outperform |
| 11/11/2022 | 274.06% | Jefferies | → $15 | Assumes | → Buy |
| 05/09/2022 | 274.06% | Canaccord Genuity | $10 → $15 | Upgrades | Hold → Buy |
| 05/05/2022 | 249.13% | SVB Leerink | $12 → $14 | Maintains | Outperform |
| 11/04/2021 | 398.75% | JMP Securities | $25 → $20 | Maintains | Market Outperform |
| 05/06/2021 | 498.5% | Canaccord Genuity | $21 → $24 | Maintains | Hold |
| 02/23/2021 | 423.69% | Canaccord Genuity | $20 → $21 | Maintains | Hold |
| 02/23/2021 | 573.32% | SVB Leerink | $23 → $27 | Maintains | Outperform |
| 10/23/2020 | 498.5% | Guggenheim | → $24 | Initiates Coverage On | → Buy |
| 08/06/2020 | 286.53% | SVB Leerink | $13.5 → $15.5 | Maintains | Outperform |
| 05/07/2020 | 199.25% | Canaccord Genuity | → $12 | Downgrades | Buy → Hold |
| 04/02/2020 | — | BTIG | Downgrades | Buy → Neutral | |
| 11/07/2019 | 523.44% | Canaccord Genuity | $30 → $25 | Maintains | Buy |
| 11/07/2019 | 373.82% | Cantor Fitzgerald | $21 → $19 | Maintains | Overweight |
| 08/07/2019 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 03/25/2019 | 598.25% | BTIG | → $28 | Upgrades | Neutral → Buy |
| 11/14/2018 | — | BTIG | Initiates Coverage On | → Neutral | |
| 10/30/2018 | 972.32% | Cantor Fitzgerald | $45 → $43 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 10/16/2023 | 124.44% | Leerink合作夥伴 | →$9 | 開始承保 | →跑贏大盤 |
| 09/26/2023 | 299% | 康託·菲茨傑拉德 | →$16 | 重申 | 超重→超重 |
| 2023年08月22日 | 299% | 康託·菲茨傑拉德 | →$16 | 重申 | 超重→超重 |
| 2023年05月10日 | 398.75% | JMP證券 | →$20 | 重申 | →市場跑贏大盤 |
| 03/28/2023 | 274.06% | 卡納科特·格納奇 | →$15 | 重申 | →購買 |
| 03/15/2023 | 398.75% | JMP證券 | →$20 | 重申 | →市場跑贏大盤 |
| 2022年11月11日 | 274.06% | 傑富瑞 | →$15 | 假設 | →購買 |
| 05/09/2022 | 274.06% | 卡納科特·格納奇 | $10→$15 | 升級 | 持有→購買 |
| 05/05/2022 | 249.13% | SVB Leerink | $12→$14 | 維護 | 跑贏大盤 |
| 11/04/2021 | 398.75% | JMP證券 | $25→$20 | 維護 | 市場表現強於大盤 |
| 05/06/2021 | 498.5% | 卡納科特·格納奇 | $21→$24 | 維護 | 保持 |
| 02/23/2021 | 423.69% | 卡納科特·格納奇 | $20→$21 | 維護 | 保持 |
| 02/23/2021 | 573.32% | SVB Leerink | $23→$27 | 維護 | 跑贏大盤 |
| 10/23/2020 | 498.5% | 古根海姆 | →$24 | 開始承保 | →購買 |
| 08/06/2020 | 286.53% | SVB Leerink | $13.5→$15.5 | 維護 | 跑贏大盤 |
| 05/07/2020 | 199.25% | 卡納科特·格納奇 | →$12 | 評級下調 | 購買→Hold |
| 04/02/2020 | - | BTIG | 評級下調 | 購買→中性 | |
| 2019/07/11 | 523.44% | 卡納科特·格納奇 | $30→$25 | 維護 | 買 |
| 2019/07/11 | 373.82% | 康託·菲茨傑拉德 | $21→$19 | 維護 | 超重 |
| 2019年08月07日 | - | 威廉·布萊爾 | 評級下調 | 跑贏→市場表現 | |
| 2019年03月25日 | 598.25% | BTIG | →$28 | 升級 | 中性→購買 |
| 2018年11月14日 | - | BTIG | 開始承保 | →中性 | |
| 2018年10月30日 | 972.32% | 康託·菲茨傑拉德 | $45→$43 | 維護 | 超重 |
What is the target price for Axogen (AXGN)?
AXGN的目標價是多少？
The latest price target for Axogen (NASDAQ: AXGN) was reported by Leerink Partners on October 16, 2023. The analyst firm set a price target for $9.00 expecting AXGN to rise to within 12 months (a possible 124.44% upside). 7 analyst firms have reported ratings in the last year.
Leerink Partners於2023年10月16日報道了阿克秀克根(納斯達克代碼：AXGN)的最新目標價。這家分析公司將目標價定為9美元，預計AXGN將在12個月內升至(可能上漲124.44)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Axogen (AXGN)?
安盛(AXGN)的最新分析師評級是多少？
The latest analyst rating for Axogen (NASDAQ: AXGN) was provided by Leerink Partners, and Axogen initiated their outperform rating.
納斯達克(Sequoia Capital：AXGN)的最新分析師評級由Leerink Partners提供，Axogen啟動了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Axogen (AXGN)?
Axogen(AXGN)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on October 16, 2023 so you should expect the next rating to be made available sometime around October 16, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Axogen的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Axogen的上一次評級是在2023年10月16日提交的，因此您應該預計下一次評級將在2024年10月16日左右提供。
Is the Analyst Rating Axogen (AXGN) correct?
分析師評級Axogen(AXGN)正確嗎？
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a initiated with a price target of $0.00 to $9.00. The current price Axogen (AXGN) is trading at is $4.01, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Axogen(AXGN)評級是以0.00美元至9.00美元的目標價啟動的。Axogen(AXGN)目前的交易價格為4.01美元，在分析師的預測範圍內。
